Tibet Cheezheng Tibetan Medicine Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000FM9
CNY
23.01
0.04 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,389.83
2,311.19
2,018.69
2,022.16
1,741.72
1,459.38
1,384.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,389.83
2,311.19
2,018.69
2,022.16
1,741.72
1,459.38
1,384.04
Raw Material Cost
466.62
474.47
382.42
382.00
309.10
242.66
202.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
48.11
60.36
66.79
61.09
56.12
23.03
4.97
Selling and Distribution Expenses
1,234.98
1,230.22
1,111.92
1,057.68
952.54
807.44
806.85
Other Expenses
2.62
0.00
-1.63
-1.36
0.75
3.40
4.77
Total Expenditure (Excl Depreciation)
1,775.88
1,765.09
1,544.88
1,487.14
1,325.22
1,107.10
1,061.93
Operating Profit (PBDIT) excl Other Income
613.9
546.1
473.8
535
416.5
352.29999999999995
322.1
Other Income
126.40
72.91
205.96
113.09
129.89
112.62
85.63
Operating Profit (PBDIT)
870.00
748.37
768.01
724.54
612.65
508.75
440.05
Interest
48.11
60.36
66.79
61.09
56.12
23.03
4.97
Exceptional Items
67.50
105.14
37.07
-3.43
4.57
0.97
2.27
Gross Profit (PBDT)
1,923.21
1,836.72
1,636.28
1,640.16
1,432.62
1,216.72
1,181.63
Depreciation
141.64
140.37
95.77
85.91
66.54
43.84
36.09
Profit Before Tax
747.74
652.78
642.52
574.11
494.55
442.85
401.26
Tax
92.37
64.87
65.24
49.56
77.09
40.78
36.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
648.43
582.28
581.20
472.54
715.88
403.96
364.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
648.43
582.28
581.20
472.54
715.88
403.96
364.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.95
-0.91
-2.02
-2.90
-5.05
0.22
0.14
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
647.47
581.37
579.18
469.64
710.83
404.18
364.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,947.66
4,064.38
3,720.33
3,335.91
3,169.03
2,619.02
2,245.54
Earnings per share (EPS)
1.19
1.1
1.1
0.89
1.35
0.76
0.69
Diluted Earnings per share
1.19
1.1
1.1
0.89
1.35
0.76
0.69
Operating Profit Margin (Excl OI)
25.19%
23.15%
23.1%
25.99%
23.9%
24.14%
23.0%
Gross Profit Margin
37.22%
34.32%
36.57%
32.64%
32.21%
33.35%
31.6%
PAT Margin
27.13%
25.19%
28.79%
23.37%
41.1%
27.68%
26.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 3.40% vs 14.49% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 11.37% vs 0.38% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 10.08% vs 20.17% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -20.36% vs -9.58% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Tibet Cheezheng Tibetan Medicine Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,389.83
0
2,389.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,389.83
0
2,389.83
Raw Material Cost
466.62
0
466.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
48.11
0
48.11
Selling and Distribution Expenses
1,234.98
0
1,234.98
Other Expenses
2.62
0.00
2.62
Total Expenditure (Excl Depreciation)
1,775.88
0
1,775.88
Operating Profit (PBDIT) excl Other Income
613.95
0.00
613.95
Other Income
126.40
0
126.40
Operating Profit (PBDIT)
870.00
0
870.00
Interest
48.11
0
48.11
Exceptional Items
67.50
0
67.50
Gross Profit (PBDT)
1,923.21
0
1,923.21
Depreciation
141.64
0
141.64
Profit Before Tax
747.74
0
747.74
Tax
92.37
0
92.37
Provisions and contingencies
0
0
0.00
Profit After Tax
648.43
0
648.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
648.43
0
648.43
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.95
0
-0.95
Other related items
0.00
0.00
0.00
Consolidated Net Profit
647.47
0
647.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,947.66
0
4,947.66
Earnings per share (EPS)
1.19
0
1.19
Diluted Earnings per share
1.19
0
1.19
Operating Profit Margin (Excl OI)
25.19%
0%
0.00
25.19%
Gross Profit Margin
37.22%
0%
0.00
37.22%
PAT Margin
27.13%
0%
0.00
27.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 238.98 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 3.40% vs 14.49% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 64.75 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.37% vs 0.38% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 74.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 10.08% vs 20.17% in Dec 2024

Annual - Interest
Interest 4.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -20.36% vs -9.58% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.19%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024